title: Autologous Hematopoietic Stem Cells transplantation and genetic modification of CCR5 m303/m303 mutant patient for HIV/AIDS.
abstract: HIV and AIDS is one of the biggest challenges all over the world. There are an approximately 34 million people living with the virus, and a large number of them become infected each year. Although there are some antiviral drugs for HIV viral load reduction, they are not sufficient. There is no cure for AIDS. Nowadays natural resistance or immunity has absorbed attentions. Because in some HIV positive patients progression trend is slow or even they indicate resistance to AIDS. One of the most interesting approaches in this category is CCR5 gene. CCR5 is a main cc-chemokine co-receptor that facilitates HIV-1 entry to macrophage and CD4(+) T cells. To now, many polymorphisms have been known by CCR5 gene that produces a truncated protein with no function. So, HIV-1 could not entry to immune-cells and the body resistant to HIV/AIDS. Δ32/Δ32 and m303/m303 homozygotes are example of mutations that could create this resistance mechanism. There is a new treatment, such as Hematopoietic Stem Cell transplantation (HSCT) in Berlin and Boston patients for Δ32/Δ32 mutation. It could eliminate co-receptor antagonist and highly-active-anti retroviral therapy (HAART) drugs problems such as toxicity, low safety and side-effects. Now there, the aim of this hypothesis will be evaluation of a new mutation CCR5 m303/m303 as autologous HSCT. This novel hypothesis indicates that autologous HSCT for m303/m303 could be effective treatment for anyone HIV/AIDS affected patient worldwide.
authors.affiliation: Department of Immunology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran; Cancer Gene Therapy Research Center, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran. Electronic address: a46reza@zums.ac.ir.
authors.forename: Abdolreza
authors.initials: A
authors.lastname: Esmaeilzadeh
authors.affiliation: Department of Genetic & Molecular Medicine, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
authors.forename: Alieh
authors.initials: A
authors.lastname: Farshbaf
authors.affiliation: Young Researchers Club, Zanjan Branch, Islamic Azad University, Zanjan, Iran.
authors.forename: Maryam
authors.initials: M
authors.lastname: Erfanmanesh
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy*; D015316:Genetic Therapy / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008954:Models, Biological; D016296:Mutagenesis / Q000235:genetics; D019713:Receptors, CCR5 / Q000235:genetics*; D014182:Transplantation, Autologous / Q000379:methods*
chemical_list: C584933:CCR5 protein, human; D019713:Receptors, CCR5